neoderm cream
birzeit pharmaceutical company (bpc) - gramicidin, neomycin (neomycin sulfate), nystatin, triamcinolone acetonide - cream - 0,25mg/g+ 2,5mg/g+ 100000iu/g+ 1mg/g
lindell 50mg/ml (5%) lotion
neoderm, inc.; distributor: britton distributions, inc. - permethrin - lotion - 50mg/ml (5%)
novosorb btm - dressing, absorbable
polynovo biomaterials pty ltd - 34615 - dressing, absorbable - the device is a sterile, fully synthetic biodegradable temporary skin substitute intended to temporize dermal injuries, where the dermis has been lost, and to facilitate dermal repair and generate a neodermis. the device is implanted and stapled/ sutured into a debrided wound bed and integrates through vascular and cellular infiltration. the device biodegrades through hydrolysis and is eventually fully resorbed in the body. the physician removes the sealing membrane for appropriate intervention. the novosorb btm is intended to temporize dermal injuries, where the dermis has been decimated or lost, and to facilitate dermal repair by providing temporary closure of the wound and a scaffold for the generation of a neodermis.
matriderm dermal matrix - dermal tissue reconstructive material, animal-derived
device technologies australia pty ltd - 59130 - dermal tissue reconstructive material, animal-derived - matriderm serves as a scaffold for tissue regeneration and modulates the formation of scar tissue. matriderm has excellent haemostyptic properties and thus reduces the risk of subgraft haematoma, for example,between the matrix and the wound bed. in addition, matriderm supports orderly healing and acts as a temporary adhesion barrier. matriderm is a three-dimensional matrix composed of native, structurally intact collagen fibrils and elastin. matriderm is used in combination with autologous split-thickness skin grafts for the reconstruction of deep dermal defects and full-thickness skin wounds in plastic reconstructive surgery and in the surgical treatment of burns, trauma and dermatological diseases. it may also be used in the treatment of poorly healing wounds requiring skin grafts (e.g. chronic wounds); for the reconstruction of mucosal defects and also under intact skin for the temporary separation of tissues, thereby preventing adherence, especially of tendons and their surrounding connective tissue, after injuries or surgical procedures. the aim of treatment with matriderm is to construct a neodermis,to improve the quality of reconstituted tissue, reduce scarring, prevent wound contraction and restore functionality.
synthetic wound matrix dressing
polynovo biomaterials pty ltd - 64853 - synthetic wound matrix dressing - the novosorb btm is intended to temporize dermal injuries, where the dermis has been decimated or lost, and to facilitate dermal repair by providing temporary closure of the wound and a scaffold for the generation of a neodermis.
polynovo novosorb btm
sonax business solutions - general hospital - the novosorb® btm is intended to temporise dermal injuries, where the dermis has been decimated or lost, and to facilitate dermal repair by providing temporary wound closure and a scaffold for the generation of a neodermis. the novosorb® btm is indicated for full or deep partial thickness burns, surgical and reconstructive wounds and trauma wounds.
tricort 1 mg/g (0.1% w/w) topical cream
neoderm, incorporated; distributor: britton distributions, inc. - triamcinolone acetonide - topical cream - 1 mg/g (0.1% w/w)
tricort 1 mg/ml (0.1% w/v) scalp lotion
neoderm incorporated; importer: n/a; distributor: britton distributions, inc. - triamcinolone acetonide - scalp lotion - 1 mg/ml (0.1% w/v)
none 50 mg/ml (5%) lotion
neoderm, incorporated; importer: n/a; distributor: brtitton distributions, inc. - permethrin - lotion - 50 mg/ml (5%)
neoderma anti-wrinkle day cream
cmi cosmetic manufacturers corp - octinoxate; oxybenzone - cream - 8.5%; 6.0% - octinoxate 8.5%; oxybenzone 6.0% - sunscreen agents